Page 98 - ARNM-3-1

Advances in Radiotherapy
& Nuclear Medicine Nanomaterials in cancer chemoimmunotherapy

chemoimmunotherapy against triple-negative breast cancer. 35. Mekonnen TW, Darge HF, Tsai HC, et al. Combination
Int J Nanomedicine. 2022;17:5209-5227. of ovalbumin-coated iron oxide nanoparticles and
doi: 10.2147/IJN.S388075 poly(amidoamine) dendrimer-cisplatin nanocomplex for
enhanced anticancer efficacy. Colloids Surf B Biointerfaces.
25. Mao W, Yoo HS. Inorganic nanoparticle functionalization 2022;213:112391.
strategies in immunotherapeutic applications. Biomater Res.
2024;28:0086. doi: 10.1016/j.colsurfb.2022.112391
doi: 10.34133/bmr.0086 36. Mittal P, Saharan A, Verma R, et al. Dendrimers: A new
race of pharmaceutical nanocarriers. Biomed Res Int.
26. Zang S, Huang K, Li J, et al. Metabolic reprogramming by 2021;2021:8844030.
dual-targeting biomimetic nanoparticles for enhanced tumor
chemo-immunotherapy. Acta Biomater. 2022;148:181-193. doi: 10.1155/2021/8844030
doi: 10.1016/j.actbio.2022.05.045 37. Song C, Ouyang Z, Liu J, et al. Core-shell tecto dendrimers
co-deliver drug/gene for immunomodulation of
27. Plaza-Oliver M, Santander-Ortega MJ, Lozano MV. Current macrophages and dendritic cells and checkpoint blockade-
approaches in lipid-based nanocarriers for oral drug promoted breast cancer chemoimmunotherapy. Nano
delivery. Drug Deliv Transl Res. 2021;11:471-497. Today. 2024;58:102437.
doi: 10.1007/s13346-021-00908-7
doi: 10.1016/j.nantod.2024.102437
28. Dabholkar N, Waghule T, Rapalli VK, et al. Lipid shell lipid 38. Zhu R, Su L, Dai J, et al. Biologically responsive plasmonic
nanocapsules as smart generation lipid nanocarriers. J Mol assemblies for second near-infrared window photoacoustic
Liq. 2021;339:117145.
imaging-guided concurrent chemo-immunotherapy. ACS
doi: 10.1016/j.molliq.2021.117145 Nano. 2020;14:3991-4006.
29. Suzuki Y, Ishihara H. Difference in the lipid nanoparticle doi: 10.1021/acsnano.9b07984
technology employed in three approved siRNA (Patisiran)
and mRNA (COVID-19 vaccine) drugs. Drug Metab 39. Mu QG, Lin G, Jeon M, et al. Iron oxide nanoparticle
targeted chemo-immunotherapy for triple negative breast
Pharmacokinet. 2021;41:100424.
cancer. Mater Today (Kidlington). 2021;50:149-169.
doi: 10.1016/j.dmpk.2021.100424
doi: 10.1016/j.mattod.2021.08.002
30. Yong SB, Ramishetti S, Goldsmith M, et al. Dual-targeted
lipid nanotherapeutic boost for chemo-immunotherapy of 40. Xu HZ, Chen FX, Li K, et al. Anti-lung cancer synergy of
cancer. Adv Mater. 2022;34:e2106350. low-dose doxorubicin and PD-L1 blocker co-delivered via
mild photothermia-responsive black phosphorus. Drug
doi: 10.1002/adma.202106350 Deliv Transl Res. 2025;15:269-290.
31. Tan X, Wang C, Zhou H, et al. Bioactive fatty acid doi: 10.1007/s13346-024-01595-w
analog-derived hybrid nanoparticles confer antibody-
independent chemo-immunotherapy against carcinoma. 41. Zhao Y, Zheng Y, Zhu Y, Li H, Zhu H, Liu T. Docetaxel-
J Nanobiotechnology. 2023;21:183. loaded M1 macrophage-derived exosomes for a safe
and efficient chemoimmunotherapy of breast cancer.
doi: 10.1186/s12951-023-01950-y J Nanobiotechnology. 2022;20:359.
32. Wei X, Liu L, Li X, et al. Selectively targeting tumor- doi: 10.1186/s12951-022-01526-2
associated macrophages and tumor cells with polymeric
micelles for enhanced cancer chemo-immunotherapy. 42. Wang Y, Xie L, Li X, Wang L, Yang Z. Chemo-immunotherapy
J Control Release. 2019;313:42-53. by dual-enzyme responsive peptide self-assembling abolish
melanoma. Bioact Mater. 2024;31:549-562.
doi: 10.1016/j.jconrel.2019.09.021
doi: 10.1016/j.bioactmat.2023.09.006
33. Wei J, Long Y, Guo R, et al. Multifunctional polymeric micelle-
based chemo-immunotherapy with immune checkpoint 43. Su L, Hao Y, Li R, et al. Red blood cell-based vaccines for
blockade for efficient treatment of orthotopic and metastatic ameliorating cancer chemoimmunotherapy. Acta Biomater.
breast cancer. Acta Pharm Sin B. 2019;9(4):819-831. 2022;154:401-411.
doi: 10.1016/j.apsb.2019.01.018 doi: 10.1016/j.actbio.2022.10.001
34. Song J, Cheng M, Xie Y, Li K, Zang X. Efficient tumor 44. Jiang X, Wu L, Zhang M, et al. Biomembrane
synergistic chemoimmunotherapy by self-augmented nanostructures: Multifunctional platform to enhance tumor
ROS-responsive immunomodulatory polymeric nanodrug. chemoimmunotherapy via effective drug delivery. J Control
J Nanobiotechnology. 2023;21:93. Release. 2023;361:510-533.
doi: 10.1186/s12951-023-01842-1 doi: 10.1016/j.jconrel.2023.08.002

Volume 3 Issue 1 (2025) 90 doi: 10.36922/arnm.8150